Deciphering the clinical implication of an obesity-related gene signature as the novel biomarker for acute myocardial infarction diagnosis.
Source check: Source checked. Not independent scientific confirmation.
Finding: Machine-learning feature selection on four GEO training expression datasets produced a five-gene obesity-related signature for acute myocardial infarction (IL1RN, TLR2, NFKBIA, MMP9 and ITLN1). Its reported AUC was 0.924 in the training analysis and 0.825 in the separate GSE59876 dataset; RT-qPCR also confirmed differential expression in AMI and control samples. These retrospective biomarker results do not establish prospective diagnostic benefit.
Technology: Machine-learning feature-gene selection using obesity-related genes and GEO expression data; the resulting signature was evaluated with ROC analysis. The article also used GSEA, CIBERSORT and ssGSEA for downstream analyses.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Machine-learning feature selection identified an obesity-related gene signature for AMI diagnosis; ROC analysis assessed its discrimination, while immune-infiltration analyses characterized associated patterns.
- Test and result
- Four GEO expression datasets were used for training analyses and one for validation. The five-gene signature had AUC 0.924 and AUC 0.825 in GSE59876; RT-qPCR confirmed differential expression in AMI and control samples.
- Limitation / still unknown
- The GEO cohort analyses are retrospective; RT-qPCR confirms differential expression, not prospective diagnostic utility or improved patient outcomes.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.1038/s41598-025-28461-0 · https://europepmc.org/article/MED/41461688
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.